T he current standard of care for endophthalmitis is greatly influenced by a large prospective randomized study in the United States-the Endophthalmitis Vitrectomy Study (EVS). 1 This study proposed three management principles:
An article from India has documented the clinical characteristics of a large series of endophthalmitis caused by Aspergillus species and has analyzed the factors that impact the visual outcome. 33 The authors stated that nearly half of the cases occurred after trauma; better functional outcome (defined as an attached retina and vision 20/400) was obtained when there was no corneal infiltrate on presentation (OR 5.40), vitreous surgery was the primary procedure (OR 4.26) , intravitreal voriconazole (OR 3.63) injection was given, and the presenting vision was Hand motions or better (OR 3.33).
Two large series of fungal endophthalmitis have been published from India in the last decade. 34, 35 In these reports, infection with filamentous fungi was higher and Aspergillus species was the most common infecting fungus. The outcome, anatomical and functional, in these combined 177 eyes was suboptimal. To improve the outcome, an early vitrectomy with or without intraocular lens explanation and intravitreal antifungal antibiotic injection were suggested. 35, 36 Explantation of intraocular lens (IOL) is advocated in delayed-onset infection, including fungal endophthalmitis. One published report indicates faster resolution of inflammation and reduced number of intravitreal injection when the IOL is explanted in chronic endophthalmitis. 37 Unlike a repertoire of antibiotics in bacterial infection, the choice of antifungal antibiotic for intravitreal injection is currently confined to only two antibiotics: amphotericin B and voriconazole. Amphotericin B is a polyene antibiotic; it binds to ergosterol to alter the permeability of cell wall. Half-life (t 1/2 ) in vitreous of noninflamed phakic eyes is 8.9 days, and in aphakic vitrectomized eye it is only 1.8 hours. Yeasts and filamentous fungi are susceptible to amphotericin B, but many species of Aspergillus are resistant. Voriconazole is a triazole compound; it inhibits ergosterol synthesis, which increases membrane permeability. Half-life of voriconazole in vitreous of noninflamed phakic eyes is 2.5-6.5 hours; it has broad-spectrum activity against molds and yeasts. 38 Bioavailability after systemic treatment is better with voriconazole than amphotericin B. However, voriconazole is a known hepatotoxic and amphotericin B is a known renal toxic. 39 The EVS recommendation for vitrectomy was based on the presenting vision: primary vitrectomy only for eyes with vision of light perception or less and vitreous tap in all other eyes. 1 Despite some contests, 2,3 this strategy holds true in care of post-cataract surgery acute bacterial endophthalmitis, but it does not extend to other forms of endophthalmitis. Vitrectomy and intravitreal antibiotic must be the primary treatment in all delayed-onset and chronic (many times fungal) endophthalmitis. The question is how much of vitrectomy should one perform in eyes that are infected and the retina vulnerable to vitreous surgery-induced manipulations. The EVS recommended only a core, not a complete, vitrectomy. 1 This again may not be enough to achieve good functional result in many instances of chronic endophthalmitis and endophthalmitis after trauma. To repair the iatrogenic retinal damage, these eyes could require a midterm tamponade such as with silicone oil. 40, 41 In addition to exerting endotamponade, silicone oil could also exert its inherent antimicrobial effect. 42 One of the advantages of routine microbiology study in endophthalmitis is estimating the minimum inhibitory concentration (MIC, defined as the lowest concentration of an antimicrobial agent that prevents visible growth of microorganisms) of the antibiotic. MICs are used to evaluate the antimicrobial efficacy of various compounds by measuring the effect of decreasing concentrations of antibiotic inhibiting microbial population growth over a defined period. 43 MICs that confirm resistance of bacterial species are performed routinely in many laboratories. MIC is not routinely performed for antifungal antibiotics. But MIC of antifungal antibiotics is required for the similar reasons that the antibacterial antibiotics MIC is performed: increasing number of people with profound immunosuppression and the possibilities of invasive fungal infection; development of new antifungal drugs; and the emergence and recognition of antifungal resistance. MIC breakpoints are available for amphotericin B, fluconazole, itraconazole, voriconazole, and flucytosine against Candida and some species of filamentous fungi. 44 It is not available for all species of filamentous fungi. One of the major deficiencies of the susceptibility testing including the MIC is the in vitro-in vivo correlation. One is equally unsure if the minimum fungicidal concentration (MFC, defined as the lowest concentration of the drug that achieves 98-99.9% killing of a particular fungus) correlates better with the clinical outcome.
These two articles in this issue 22, 33 raise some important questions: (1) Should one continue to identify the infecting microorganisms in view of the current recommendations of empirical selection of intravitreal antibiotics? (2) Should one continue to depend on classic stain and culture methods? (3) Should not one consider including intravitreal antifungal antibiotic in combination with the antibacterial antibiotics in primary care of endophthalmitis in the regions of the world where fungal infection is not uncommon? The answers, in short, could probably be "yes" for continuing detection of infecting organisms but with newer molecular techniques, for susceptibility testing with greater emphasis on MIC and MFC, and for region-specific different combination of intravitreal antibiotics.
